Legacy Community Health Services, Inc.

Audits
3
Findings
44
Total Expended
$86.88M
Latest Accepted
2025-07-29
Location: Houston, TX
UEI: HFQGQ4MNA2L4 EIN: 760009637

SAM.gov Exclusion Status:

Checking exclusion status...

Contacts

Name Title Type
Rebekah Le Interim Chief Operating Officer Auditee
Jansen Otterness Partner Auditee
Delayna Judy VP of Accounting Auditee
Ben Glisan CHIEF FINANCIAL OFFICER Auditee
Jeff Allen Partner Auditee
No contacts on file

Recent Audits

ID Year Date Accepted Auditor Spend
363301 2024 2025-07-29 Forvis Mazars LLP $20.46M
300967 2023 2024-03-29 Forvis LLP $34.03M
18977 2022 2023-03-28 Forvis LLP $32.40M

Audit Findings

Audit Year Accepted Finding Ref Severity Repeat Requirement
363301 2024 2025-07-29 1148642 2024-003 Significant Deficiency - E
363301 2024 2025-07-29 1148641 2024-003 Significant Deficiency - E
363301 2024 2025-07-29 1148640 2024-003 Significant Deficiency - E
363301 2024 2025-07-29 1148639 2024-003 Significant Deficiency - E
363301 2024 2025-07-29 1148638 2024-003 Significant Deficiency - E
363301 2024 2025-07-29 1148637 2024-003 Significant Deficiency - E
363301 2024 2025-07-29 1148636 2024-003 Significant Deficiency - E
363301 2024 2025-07-29 1148635 2024-003 Significant Deficiency - E
363301 2024 2025-07-29 1148634 2024-003 Significant Deficiency - E
363301 2024 2025-07-29 1148633 2024-003 Significant Deficiency - E
363301 2024 2025-07-29 1148632 2024-002 Material Weakness - B
363301 2024 2025-07-29 1148631 2024-002 Material Weakness - B
363301 2024 2025-07-29 1148630 2024-002 Material Weakness - B
363301 2024 2025-07-29 1148629 2024-002 Material Weakness - B
363301 2024 2025-07-29 1148628 2024-002 Material Weakness - B
363301 2024 2025-07-29 1148627 2024-002 Material Weakness - B
363301 2024 2025-07-29 1148626 2024-002 Material Weakness - B
363301 2024 2025-07-29 1148625 2024-002 Material Weakness - B
363301 2024 2025-07-29 1148624 2024-002 Material Weakness - B
363301 2024 2025-07-29 1148623 2024-002 Material Weakness - B
363301 2024 2025-07-29 1148622 2024-002 Material Weakness - B
363301 2024 2025-07-29 1148621 2024-002 Material Weakness - B
363301 2024 2025-07-29 572200 2024-003 Significant Deficiency - E
363301 2024 2025-07-29 572199 2024-003 Significant Deficiency - E
363301 2024 2025-07-29 572198 2024-003 Significant Deficiency - E
363301 2024 2025-07-29 572197 2024-003 Significant Deficiency - E
363301 2024 2025-07-29 572196 2024-003 Significant Deficiency - E
363301 2024 2025-07-29 572195 2024-003 Significant Deficiency - E
363301 2024 2025-07-29 572194 2024-003 Significant Deficiency - E
363301 2024 2025-07-29 572193 2024-003 Significant Deficiency - E
363301 2024 2025-07-29 572192 2024-003 Significant Deficiency - E
363301 2024 2025-07-29 572191 2024-003 Significant Deficiency - E
363301 2024 2025-07-29 572190 2024-002 Material Weakness - B
363301 2024 2025-07-29 572189 2024-002 Material Weakness - B
363301 2024 2025-07-29 572188 2024-002 Material Weakness - B
363301 2024 2025-07-29 572187 2024-002 Material Weakness - B
363301 2024 2025-07-29 572186 2024-002 Material Weakness - B
363301 2024 2025-07-29 572185 2024-002 Material Weakness - B
363301 2024 2025-07-29 572184 2024-002 Material Weakness - B
363301 2024 2025-07-29 572183 2024-002 Material Weakness - B
363301 2024 2025-07-29 572182 2024-002 Material Weakness - B
363301 2024 2025-07-29 572181 2024-002 Material Weakness - B
363301 2024 2025-07-29 572180 2024-002 Material Weakness - B
363301 2024 2025-07-29 572179 2024-002 Material Weakness - B